Cite
HARVARD Citation
Erlandsson, F. et al. (n.d.). Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator. British journal of clinical pharmacology. pp. 1486-1493. [Online].